Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Crisaborole in Mild-to-Moderate Alopecia Areata
NCT04299503Phase 2Withdrawn
- Sponsor
- Tufts Medical Center
- Start
- Mar 2020
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
A Phase 2 trial of AN2728 ointment vehicle in alopecia areata, sponsored by Tufts Medical Center. Planned start Mar 2020; status: withdrawn.
02
Drugs
AN2728 ointment vehicle
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT04299503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04299503.